Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of obesity. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://murraycxeb827288.dreamyblogs.com/39350429/semaglutide-a-potential-solution-for-diabetes